Molecular Diagnostics

Veracyte to share bundle of genomic classifier studies at AUA 2024
By LabPulse.com staff writers
Veracyte has announced that the American Urological Association's May meeting will feature nine sessions related to evaluations of its prostate cancer and bladder cancer genomic tests.
April 16, 2024
Prostate Cancer 3 D Rendering Social
Labcorp expands precision oncology offerings
By Matt Limb
Laboratory services firm Labcorp has announced the expansion of its precision oncology portfolio, aimed at supporting clinical research and advancing drug development programs.
April 12, 2024
Labcorp Rtp 10 Med Res 950h 6x4 Social
Urine test halves use of invasive procedure to monitor bladder cancer
By Nick Paul Taylor
A urine test can cut the number of cystoscopies necessary to follow up high-risk bladder cancer patients without increasing the risk of recurrence, a study has found.
April 11, 2024
Bladder Urinary 3 D Social
Molecular diagnostic test study continues EET benefit assessment
By Liz Carey
A molecular oncology gene expression profiling (GEP) test for breast cancer biomarkers may influence extended endocrine therapy (EET) treatment decisions, according to an impact study.
April 2, 2024
Dna Sequence Shadow Social
MIT team develops genome-editing approach for cancer mutation screening
By Matt Limb
Scientists say they have developed a method to screen cancer-associated genetic mutations more easily and quickly than any existing approach.
March 22, 2024
Dna Cancer Cell Social
Highlights of March 2024 LDT hearing with lawmakers
By Liz Carey
The VALID Act appeared to win hearts over the hammer of a forthcoming FDA final rule expected to drop heavy regulations on clinical laboratory developed tests (LDTs), a hearing of the House Subcommittee on Health revealed Thursday.
March 22, 2024
Rothstein Adva Med Dx Ldt Hearing 2024 You Tube Social
Oxford Nanopore, SeqOne to collaborate on sequencing platform
By LabPulse.com staff writers
Oxford Nanopore and genomics firm SeqOne are collaborating on an end-to-end platform for whole-genome nanopore sequencing reads for clinical diagnostic testing.
March 18, 2024
Dna Sequencing Data Analysis Social
Curio Bioscience to offer single-cell spatial mapping kit
By Matt Limb
Curio Bioscience is offering researchers early access to a product which it claims is the first in the world to transform single-cell genomics data into spatial context.
March 19, 2024
Genome Sequence Barcode Social
NGeneBio, Genolution to collaborate on automated NGS system
By LabPulse.com staff writers
Precision diagnostics company NGeneBio and molecular diagnostics firm Genolution have signed a memorandum of understanding to develop and launch an automated next-generation sequencing (NGS) system.
March 14, 2024
Business Handshake Intelligence Social
Gene-based technique shows potential for rapid diagnostics
By LabPulse.com staff writers
Biomedical engineers have developed a new gene-based approach which can be used on test strips for rapid, on-the-spot disease detection with accuracy comparable to that of lab-based polymerase chain reaction (PCR) tests.
March 7, 2024
Sequencing Virus Social
AMDI receives $5.2M in RADx Tech funding for PCR viral testing system
By LabPulse.com staff writers
Autonomous Medical Devices Incorporated (AMDI) has received a U.S. National Institutes of Health (NIH) RADx Tech award of up to $5.2 million to finalize its rapid point-of-care viral testing system.
March 4, 2024
Money Bag Grant Award Social
Reversible, multiplex CRISPR system enhances efficacy of CAR-T cell therapy
By Nick Paul Taylor
A CRISPR system that uses Cas13d to make reversible changes to the expression of multiple genes could overcome limitations that are holding back CAR-T cell therapies, a paper published in Cell suggests.
February 28, 2024
Licensed under Creative Commons
Page 1 of 193
Next Page